Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Padovan

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2016
Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agentsM E Mancuso, V Chantarangkul, M Clerici, et al.
The American Journal of Pathology|April 18, 1998
Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervixP Tenti, S Pavanello, L Padovan, et al.
Anticancer Research|November 29, 2001
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesionsA L Scovassi, N S Pellegata, L Di Stefano, et al.
Chirurgia Italiana|February 1, 1985
[Blood coagulation in 222 cases of solid malignant neoplasms]A M Padoan, A Di Tommaso, C Zerbinati, et al.
Journal of Endocrinological Investigation|June 11, 2021
Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of diseaseE Ferrante, A L Serban, M Clerici, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 21, 2016
Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agentsM E Mancuso, V Chantarangkul, M Clerici, et al.
The American Journal of Pathology|April 18, 1998
Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervixP Tenti, S Pavanello, L Padovan, et al.
Anticancer Research|November 29, 2001
Effects of topoisomerase II inhibitors on gastric cancer cells characterized by different genetic lesionsA L Scovassi, N S Pellegata, L Di Stefano, et al.
Chirurgia Italiana|February 1, 1985
[Blood coagulation in 222 cases of solid malignant neoplasms]A M Padoan, A Di Tommaso, C Zerbinati, et al.
Journal of Endocrinological Investigation|June 11, 2021
Evaluation of procoagulant imbalance in Cushing's syndrome after short- and long-term remission of diseaseE Ferrante, A L Serban, M Clerici, et al.
Pageof 2